# Scripps Research Institute

Scripps Research Institute is an Endowment / Foundation based in La Jolla, United States.

## Overview

- **Organization type:** Endowment / Foundation
- **Headquarters:** La Jolla, United States
- **Region:** North America
- **Address:** 10550 North Torrey Pines Road, La Jolla, CA 92037, United States
- **Founded:** 1924
- **Assets under management:** 541 (Altss estimate)
- **Website:** scripps.edu
- **LinkedIn:** https://www.linkedin.com/school/the-scripps-research-institute/

## Regulatory record

- **Reports private funds:** No

## About

Scripps Research Institute was founded in 1924 by Ellen Browning Scripps as a nonprofit medical research facility. Peter G. Schultz serves as president and CEO. The organization operates graduate training programs and drug development arms including Calibr. The institute allocates across private equity, venture capital, and real estate. Confirmed holdings include Protego Biopharma and Uvax Bio. It maintains positions in the United States and has executed exits such as Vividion Therapeutics. Geographic reach covers California research sites and prior Florida operations now integrated with University of Florida. Assets total 541 million dollars with 2100 employees. Additional offices are absent after the 2022 campus transfer. Adjacent vehicles include the Scripps Research Translational Institute established in 2007 and the Calibr-Skaggs Institute for Innovative Medicines. May 2024 marked the opening of the Chi-Huey Wong Laboratories facility on the La Jolla campus. The structure separates research operations from investment management through an external OCIO relationship with Strategic Investment Group. Board oversight rests with John D. Diekman and Thomas Daniel. This setup channels royalty income from over 1100 patents directly into laboratory construction and spin-off formation.

## Sectors

- Healthcare
- Biotechnology

## People

- Peter G. Schultz — President and CEO
- John D. Diekman — Chairman of the Board

## Questions

### Who runs investment decisions at Scripps Research Institute?

Peter G. Schultz serves as president and CEO. External managers including Portfolio Advisors and HarbourVest Partners handle portfolio allocation under board supervision.

### Does Scripps Research Institute participate in fund commitments or only direct deals?

The institute holds both fund interests such as Varde Private Debt Opportunities Fund and direct ownership in biotechnology startups including Protego Biopharma and Uvax Bio.

### What investment stages does Scripps Research Institute typically target?

Activity focuses on early-stage biotechnology companies and seed through expansion rounds. Exits have included Vividion Therapeutics and Abide Therapeutics.

### How is Scripps Research Institute related to its spin-off companies?

Faculty members including Benjamin Cravatt and Paul Schimmel founded multiple portfolio companies. Ownership passes through the institute or affiliated entities such as Calibr.

## Related profiles

- [Navis Wealth Advisors](https://altss.com/profile/navis-wealth-advisors)
- [PREVCOM](https://altss.com/profile/prevcom)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/scripps-research-institute

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology